This week in Other Barks & Bites: Stanford University suffers another Section 101 loss at the Federal Circuit for its haplotype phase determination patent claims; the EU’s highest court rules that the existence of a manufacturing process patent involving a pharmaceutical composition in the public domain is not an insurmountable barrier to competition; China’s IP administration announces a special enforcement campaign against entities engaging in malicious trademark squatting; the Fourth Circuit finds domain name claims filed against the Republic of France are barred by sovereign immunity; a jury verdict in Eastern Texas finds Apple liable for $308.5 million in reasonable royalties for infringing digital rights management patent claims; and the U.S. Copyright Office seeks public comment on implementing rules and procedures for the Copyright Claims Board established by the CASE Act.
Patent
- Enablement
- Fee Shifting
- Litigation
- SCOTUS Sustains Blow to Patent Prosecution Practice in Denying Juno v. Kite Rehearing
- Opinion: Restoring The Road Less Traveled – American Invention at a Crossroad
- An Alternative to Claim Mirroring in Initial Patent Application Filing
- Bristol Myers Says AstraZeneca’s Imjudo Infringes Yervoy Patent
- New Federal Law and FTC Rule Will Imperil Trade Secret Protection
Recent Posts
- SCOTUS Sustains Blow to Patent Prosecution Practice in Denying Juno v. Kite Rehearing
- Opinion: Restoring The Road Less Traveled – American Invention at a Crossroad
- An Alternative to Claim Mirroring in Initial Patent Application Filing
- Bristol Myers Says AstraZeneca’s Imjudo Infringes Yervoy Patent
- New Federal Law and FTC Rule Will Imperil Trade Secret Protection